Put companies on watchlist
bonyf NV
ISIN: BE6333353298
WKN: A3D1EU
Curious about what AI knows about Bonyf? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

bonyf NV · ISIN: BE6333353298 · EQS - Company News (14 News)
Country: Belgium · Primary market: Belgium · EQS NID: 2078435
30 January 2025 11:21PM

bonyf R&D presents its two latest innovations at IDS 2025 in Cologne


bonyf NV / Key word(s): Product Launch/Market Launch
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

30-Jan-2025 / 23:21 CET/CEST


bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

fncls.ssp?fn=download2_file&code_str=d910ba8222bb131711e0aef062a8ab3a

Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of oral, denture, orthodontic, and wound care products. As a leader in dental care innovation, bonyf R&D presents its 2 latest innovations at the dental future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community in Cologne. Visit bonyf at the IDS Hall 5.2, Booth 131.

The dental world is meeting up in Cologne:

The International Dental Show (IDS) is celebrating its 41st edition this year. From 25-29 March 2025, the International Dental Show is taking place in Cologne for the 41st time and will once again underline its position as the world's leading trade fair for dentistry and dental technology. Organised by the GFDI (Gesellschaft zur Förderung der Dental-Industrie mbH) and staged by Koelnmesse, IDS brings the most important players of the dental profession, the dental technology trade, the dental specialised trade and the dental industry together and offers a unique platform for innovations, networking and knowledge transfer.

bonyf showcases its 2 newest innovative groundbreaking developments applicable by dental professionals:

Advanced Dental Bleaching & Gum Reinforcement Kit:

More than just a whitening solution, this innovative system not only delivers superior bleaching results but also actively helps to reinforce the gums. By promoting gum health alongside bleaching, this product is uniquely positioned to address both aesthetic and oral health needs. Especially formulated for end users.

Post-Scaling Care Kit:

Exclusively designed for dentists, this kit addresses common post-scaling challenges, significantly reducing pain and bleeding to enhance patient comfort and satisfaction.

Jean Pierre Bogaert, CEO of bonyf: “Participating at IDS is a tremendous opportunity for us to showcase our commitment to improving dental health and care,” “We are excited to introduce these cutting-edge solutions to the global dental community and contribute to shaping the future of dentistry.”

Visit bonyf at IDS Hall 5.2 B-131 to discover the latest innovations of the bonyf R&D department at firsthand.

For more information or to schedule a meeting at IDS 2025, please contact: investor@bonyf.com

bonyf’s strengths

  • Products with patented formulations
  • Produced in Switzerland compliant with stringent international quality regulations
  • Proven clinical efficacy
  • Commercial presence in 37 countries
  • Prospects for solid growth and rapid profitability
  • A fast-growing oral and dental care market

 

fncls.ssp?fn=download2_file&code_str=e7d0ebe20cbb321ea465fb173e44c656

About bonyf

Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market.

For more information about bonyf and its innovative oral care products, please visit www.bonyf.com.

 

bonyf

Jean-Pierre Bogaert

investor@bonyf.com

fncls.ssp?fn=download2_file&code_str=ac52c3e68854f9771e2e9bb3ef1e820f

 



Dissemination of a Financial Wire News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Language: English
Issuer: bonyf NV
Kalvekeetdijk 179, box 105
8300 Knokke-Heist
Belgium
Phone: +41 79 412 42 79
E-mail: president@bonyf.com
Internet: www.bonyf.com
ISIN: BE6333353298
EQS News ID: 2078435

 
End of Announcement - EQS News Service

2078435  30-Jan-2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2078435&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
MIC: XPAR

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.